AstraZeneca explains the withdrawal of the vaccine from use as “a surplus of the current available versions” of vaccines against the SARS-CoV-2 coronavirus, which has caused a global pandemic. Because of the virus’s many mutations, pharmaceutical companies are working to develop vaccines that target new variants that appear regularly.
AstraZeneca: Our Covid-19 vaccine saved the lives of 6.5 million people in the first year of its use
In March, AstraZeneca asked the European Union to withdraw approval for the use of the company’s vaccine on the European market. On May 7, the European Medicines Agency announced that the vaccine was no longer authorized for use in Europe.
AstraZeneca confirms that it is withdrawing the vaccine because there are now a whole host of newer vaccines on the market that have been adapted to combat new variants of the SARS-CoV-2 coronavirus, which has led to a decline in demand for the AstraZeneca vaccine. This company’s vaccine, one of the first vaccines against the SARS-CoV-2 coronavirus approved for use, is no longer in production.
“According to independent estimates, more than 6.5 million lives were saved in the first year of use (of the vaccine) alone,” the company’s announcement said, adding that it had supplied a total of more than 3 billion doses of the vaccine to various countries. around the world.
